In accordance with the ultimate assistance for the next cycle from the Drug Price Negotiation Method, drug firms with a selected drug could have until eventually February 28, 2025 to decide if they may participate in negotiations. In negotiating with collaborating companies, CMS will look at the selected drug’s scientific gain, the extent to whic